AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025)

AbCellera Biologics' Construction in Progress history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• Quarterly Construction in Progress fell 97.87% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (down 97.87% YoY) and the FY2025 annual result came in at $2.2 million, down 97.87% from the prior year.
• Construction in Progress was $2.2 million for Q4 2025 at AbCellera Biologics, down from $118.7 million in the prior quarter.
• Across five years, Construction in Progress topped out at $118.7 million in Q3 2025 and bottomed at $2.2 million in Q4 2025.
• A 3-year average of $31.4 million and a median of $15.2 million in 2024 frame the typical range for Construction in Progress.
• Peak annual rise in Construction in Progress reached 670.78% in 2025, while the deepest fall reached 97.87% in 2025.
• AbCellera Biologics' Construction in Progress stood at $13.7 million in 2023, then jumped by 653.28% to $103.2 million in 2024, then plunged by 97.87% to $2.2 million in 2025.
• Business Quant data shows ABCL's Construction in Progress at $2.2 million in Q4 2025, $118.7 million in Q3 2025, and $23.1 million in Q2 2025.